News Release: Hamari HQ

Hamari on winter break

Hamari will be closed for the winter break from December 30, 2020 until January 4th, 2021. See you next year!

Hamari will present at Dietitians Australia 2021 Conference

Hamari Chemicals, Ltd. was invited to present at
the Dietitians Australia 2021 Conference
in July 11-13, 2021.

Functional dyspepsia and Gastro-esophageal reflux disease are two highly prevalent upper GIT disorders, which significantly impair quality of life. Chelated compounds of zinc have demonstrated efficacy for addressing the symptoms and underlying drivers of upper digestive complaints and represent a compelling support to conventional drug therapy. Attendees will understand the evidence for, indications and contraindications for these key clinically trialed nutritional compounds.

Hamari will have a 20 minutes presentation focusing on PepZin GI’s safety and efficacy.

[Review Articles] Review articles on the synthesis of common APIs using Tailor-Made Amino Acids

Several review articles on the synthesis of typical active pharmaceutical ingredients using Hamari’s Tailor-Made Amino Acids as starting materials and synthetic intermediates were published.

Applications of fluorine-containing amino acids for drug design.
Eur. J. Med. Chem. 2020, 186, 111826.

Tailor-made amino acids and fluorinated motifs as prominent traits in modern pharmaceuticals.
Chem. Eur. J. 2020, 26, 11349-11390. [Reviews Showcase]

Cyclic tailor-made amino acids in the design of modern pharmaceuticals.
Eur. J. Med. Chem. 2020, 208, 112736.

We, at Hamari Chemicals, Ltd., would like to express our gratitude for having received knowledge, education and support from academia, businesses and society, by sharing our discoveries at various academic societies, and publishing research articles and patents.
Hamari’s list of publications